Free Trial

Curaleaf (OTCMKTS:CURLF) Trading Down 0.5% - Should You Sell?

Curaleaf logo with Medical background
Remove Ads

Curaleaf Holdings, Inc. (OTCMKTS:CURLF - Get Free Report) shares fell 0.5% during mid-day trading on Thursday . The stock traded as low as $1.33 and last traded at $1.37. 340,191 shares traded hands during trading, a decline of 48% from the average session volume of 659,549 shares. The stock had previously closed at $1.38.

Analyst Upgrades and Downgrades

Several analysts have weighed in on the stock. Cormark lowered shares of Curaleaf from a "moderate buy" rating to a "hold" rating in a research note on Thursday, November 7th. Roth Capital raised shares of Curaleaf to a "strong-buy" rating in a research report on Sunday, November 10th.

View Our Latest Analysis on CURLF

Curaleaf Stock Up 10.2 %

The company has a quick ratio of 0.51, a current ratio of 1.11 and a debt-to-equity ratio of 0.85. The firm's 50 day simple moving average is $1.73 and its 200 day simple moving average is $2.75. The company has a market cap of $981.33 million, a price-to-earnings ratio of -5.21 and a beta of 0.64.

About Curaleaf

(Get Free Report)

Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.

Featured Articles

Should You Invest $1,000 in Curaleaf Right Now?

Before you consider Curaleaf, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Curaleaf wasn't on the list.

While Curaleaf currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

5 Stocks to BUY NOW in February 2025

5 Stocks to BUY NOW in February 2025

With the market holding strong, inflation concerns persisting, and major earnings reports ahead, these stock picks could be game-changers for your portfolio!

Recent Videos

Best ETFs for Spring 2025: Strong and Steady Investing
Is There Still Money in AI? How to Invest in the Next Big Wave
AMD at Rock Bottom? Analysts Predict a MAJOR Rebound!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads